Moxifloxacin

Generic Name: Moxifloxacin Hydrochloride

Brand Names: Avelox, Vigamox

Moxifloxacin is a fluoroquinolone antibiotic used to treat respiratory infections, skin infections, and certain eye infections.

AntibioticFluoroquinolone

Drug Class

Fourth-Generation Fluoroquinolone Antibiotic

Pregnancy

Category C — Animal studies have shown adverse effects on fetal development at doses higher than human therapeutic doses. There are no adequate well-controlled studies in pregnant women. Fluoroquinolones are generally avoided during pregnancy unless no safer alternative is available because of theoretical concerns about fetal cartilage and joint development.

Available Forms

Oral tablet (400 mg), IV solution for infusion (400 mg/250 mL premixed), Ophthalmic solution (0.5% — Vigamox, Moxeza)

What It's Used For

Dosage Quick Reference

These are general dosage guidelines. Your doctor will determine the appropriate dose for your specific situation.

Condition	Starting Dose	Maintenance Dose
Community-acquired pneumonia	400 mg PO or IV once daily	400 mg once daily for 7–14 days
Acute bacterial sinusitis	400 mg PO once daily	400 mg once daily for 10 days
Acute exacerbation of chronic bronchitis	400 mg PO once daily	400 mg once daily for 5 days
Complicated skin and soft tissue infection	400 mg PO or IV once daily	400 mg once daily for 7–21 days
Complicated intra-abdominal infection	400 mg IV once daily, then PO	400 mg once daily for 5–14 days
Bacterial conjunctivitis (ophthalmic)	1 drop in affected eye(s) three times daily	Continue 7 days

Side Effects

Common Side Effects:

Nausea and vomiting
Diarrhea
Dizziness
Headache
Abdominal pain

Serious Side Effects:

Tendinitis and tendon rupture
QT prolongation and Torsades de pointes
Peripheral neuropathy
CNS effects (seizures, confusion, psychosis)
Clostridium difficile colitis
Hepatotoxicity
Hypersensitivity reactions

Drug Interactions

Moxifloxacin has several clinically important interactions, particularly involving QT prolongation and absorption.

QT-prolonging agents (e.g., amiodarone, sotalol, ondansetron, methadone, antipsychotics, citalopram): Moxifloxacin prolongs the QT interval more than most other fluoroquinolones. Combination significantly raises the risk of torsades de pointes; avoid concurrent use when possible and obtain baseline ECG in higher-risk patients.
Multivalent cation-containing products (antacids with aluminum, magnesium, calcium; iron; zinc; sucralfate; multivitamins): Form chelation complexes with moxifloxacin that drastically reduce absorption. Take moxifloxacin at least 4 hours before or 8 hours after these products.
Warfarin: Moxifloxacin can enhance warfarin's anticoagulant effect, raising INR and bleeding risk, partly through gut flora alteration. Monitor INR more frequently during co-administration.
NSAIDs: Theoretical concern for additive CNS stimulation and seizure risk, particularly in patients with epilepsy. Use cautiously in those with seizure history.
Corticosteroids: Concurrent systemic corticosteroid use significantly increases the risk of fluoroquinolone-associated tendinitis and tendon rupture, particularly in adults over 60. Counsel patients to report new joint or tendon pain immediately.
Antidiabetic agents (insulin, sulfonylureas): Fluoroquinolones can cause both hypoglycemia and hyperglycemia. Monitor glucose more closely, particularly in older adults with diabetes.

Additional Information

Moxifloxacin is a fourth-generation fluoroquinolone antibiotic with broad-spectrum activity against gram-positive, gram-negative, and atypical bacteria. It is commonly used for respiratory tract infections, skin infections, and intra-abdominal infections, offering excellent tissue penetration and once-daily dosing convenience.

Mechanism of Action

Moxifloxacin exerts its bactericidal effects by inhibiting two essential bacterial enzymes:

DNA gyrase (topoisomerase II): Required for DNA replication, transcription, repair, and recombination
Topoisomerase IV: Essential for chromosome segregation during bacterial cell division

By inhibiting these enzymes, moxifloxacin prevents bacterial DNA synthesis and leads to cell death. Its 8-methoxy group provides enhanced activity against gram-positive organisms and anaerobes compared to earlier fluoroquinolones, making it particularly effective for respiratory pathogens.

Available Formulations

Oral tablets: 400 mg film-coated tablets
IV solution: 400 mg/250 mL for intravenous infusion
Ophthalmic solution: 0.5% (for bacterial conjunctivitis treatment)

Oral and IV doses are bioequivalent, allowing easy conversion between routes without dose adjustment. This provides flexibility in transitioning hospitalized patients to outpatient oral therapy.

Medical Uses

FDA-Approved Indications:

Community-acquired pneumonia (CAP) including multidrug-resistant Streptococcus pneumoniae
Acute bacterial sinusitis
Acute bacterial exacerbation of chronic bronchitis
Complicated and uncomplicated skin and skin structure infections
Complicated intra-abdominal infections (in combination with metronidazole or alone)
Plague (Yersinia pestis) - prophylaxis and treatment
Bacterial conjunctivitis (ophthalmic formulation)

Dosing Guidelines

Adults:

Most infections: 400 mg once daily orally or IV
Duration: 5-21 days depending on infection type
Community-acquired pneumonia: 7-14 days
Acute bacterial sinusitis: 10 days
Complicated intra-abdominal infections: 5-14 days
Plague: 10-14 days

No dose adjustment is typically needed for renal or mild-to-moderate hepatic impairment due to balanced elimination.

Important Safety Information

Black Box Warnings:

Disabling and potentially irreversible adverse reactions affecting tendons, muscles, joints, nerves, and central nervous system
Exacerbation of myasthenia gravis symptoms
Reserved for conditions without satisfactory alternative treatment options for certain infections

Contraindications:

Known hypersensitivity to moxifloxacin or any fluoroquinolone
Myasthenia gravis (may exacerbate muscle weakness)

Serious Warnings and Precautions:

QT prolongation: Avoid in patients with known QT prolongation, hypokalemia, or those taking Class IA or III antiarrhythmics
Tendinitis and tendon rupture risk: Increased with age >60, corticosteroid use, and organ transplantation
Peripheral neuropathy: Discontinue immediately if symptoms develop
CNS effects: May cause seizures, increased intracranial pressure, confusion, and toxic psychosis
Clostridium difficile-associated diarrhea: Monitor for colitis symptoms
Blood glucose disturbances: Hypoglycemia and hyperglycemia reported

Drug Interactions

QT-prolonging drugs: Additive arrhythmia risk; avoid concurrent use with antiarrhythmics, antipsychotics, tricyclic antidepressants
Antacids, iron, zinc, multivitamins: Chelate with moxifloxacin; administer moxifloxacin 4 hours before or 8 hours after
Warfarin: Enhanced anticoagulant effect; monitor INR closely
NSAIDs: May increase CNS stimulation and seizure risk
Corticosteroids: Increased tendon rupture risk; avoid concurrent use when possible
Sucralfate: Reduces moxifloxacin absorption; separate administration timing

Special Populations

Renal Impairment: No dose adjustment required for any degree of renal dysfunction
Hepatic Impairment: Use with caution in moderate-to-severe impairment; limited data available
Pregnancy: Category C; use only if benefits outweigh potential fetal risks
Pediatric: Not recommended due to musculoskeletal adverse effects in animal studies
Elderly: Increased risk of tendon disorders and QT prolongation; monitor carefully

Frequently Asked Questions

Fluoroquinolones, including moxifloxacin, carry FDA boxed warnings about disabling and potentially permanent side effects involving tendons, muscles, joints, peripheral nerves, and the central nervous system. Because of this, fluoroquinolones should be reserved for infections where no other suitable option exists. Discuss alternatives with your provider for less serious infections.

Moxifloxacin binds to multivalent metal ions — calcium, magnesium, aluminum, iron, zinc — forming complexes that the gut cannot absorb. Taking it within a few hours of antacids, calcium-fortified foods, multivitamins with iron or zinc, or sucralfate can cut absorption by more than half and cause treatment failure. Take moxifloxacin at least 4 hours before, or 8 hours after, these products.

Stop the medication immediately and contact your provider. Fluoroquinolone-associated tendinitis and tendon rupture — most often the Achilles tendon — can occur during therapy or weeks after stopping. Risk is highest in adults over 60, those on corticosteroids, and transplant recipients. Avoid strenuous exercise of the affected limb until evaluated.

Yes. Moxifloxacin prolongs the QT interval on the ECG and can rarely cause torsades de pointes — a dangerous ventricular arrhythmia. Risk is highest in patients with low potassium or magnesium, pre-existing QT prolongation, bradycardia, or those taking other QT-prolonging medications. Tell your provider about all your medications before starting moxifloxacin.

Moxifloxacin has broader activity against gram-positive bacteria (including Streptococcus pneumoniae) and anaerobes than ciprofloxacin, making it useful for community-acquired pneumonia and intra-abdominal infections. However, it achieves lower urinary concentrations than ciprofloxacin or levofloxacin and is not used for urinary tract infections.

Questions to Ask Your Doctor

Consider discussing these topics at your next appointment:

✓Is there a non-fluoroquinolone antibiotic that could treat my infection effectively?
✓Given my age and other medications, how high is my risk for tendon or nerve side effects?
✓Are any of my current prescriptions or supplements going to interact with moxifloxacin?
✓What signs should make me stop moxifloxacin and call you immediately?
✓How will we know the infection is responding, and when should I follow up?

Schedule an Appointment

Related Health Conditions

This medication is commonly used to treat or manage the following conditions:

Sinusitis

Sinusitis involves sinus inflammation and blockage due to infections, allergies, or structural issues, causing facial pain, pressure, and congestion, often following colds or triggered by allergens.

Learn More

Chronic Obstructive Pulmonary Disease (COPD)

COPD, a progressive lung disease causing irreversible airflow limitation, encompassing emphysema and chronic bronchitis, is primarily driven by irritant exposure like smoking, leading to shortness of breath and chronic cough.

Learn More

Diabetic Neuropathy

Diabetic neuropathy, a complication of diabetes caused by high blood sugar, damages nerves, leading to pain, numbness, and issues affecting various bodily systems, especially in extremities.

Learn More

Osteoarthritis

Osteoarthritis, a common degenerative joint disease, causes pain, stiffness, and reduced motion due to cartilage breakdown from aging, genetics, obesity, injuries, or repetitive stress.

Learn More

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.